Skip to search formSkip to main contentSkip to account menu

dapiprazole

Known as: Dapiprazolum, Dapiprazol, 1,2,4-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Purpose. The authors investigated the use of dapiprazole, an alpha-adrenergic blocking agent, in preventing pigment release and… 
1996
1996
PURPOSE In this investigation the authors studied the effect of dapiprazole, an alpha-adrenergic blocking agent, on aqueous humor… 
1995
1995
Abstract• Background: Since dapiprazole on alpha-adrenergic agent, produces miosis by paralyzing the dilator muscle, and… 
1993
1993
BACKGROUND Clinical interest in ophthalmic agents to reverse pharmacologically induced mydriasis safely has been attempted for… 
1991
1991
The activity of dapiprazole, clonidine and a placebo were studied to reduce abstinence symptoms and modify the psychological… 
1990
1990
The effect of topical dapiprazole, an alpha-adrenergic receptor blocker, in reversing mydriasis was studied in 50 subjects who… 
1988
1988
Trazodone and dapiprazole displace ligands binding to rat brain alpha-1 adrenoceptors. The displacement of 3H-ligands to alpha-2… 
1982
1982
The effects of 3-[2-[4-(2-methylphenyl)-1- piperazinyl]ethyl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine HCl (dapiprazole… 
1982
1982
A study of the general pharmacology of 3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-5,6,7,8-tetrahydro-1,2,4-triazolo-[4,3…